FDA Clears First OTC Continuous Blood Glucose Monitor
WEDNESDAY, March 6, 2024 -- The U.S. Food and Drug Administration on Tuesday approved the country ' s first continuous glucose monitor for type 2 diabetes.
The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Food and Drug Administration (FDA) | General Medicine